Artrya Limited (AYA.AX)
ASX · AUD · Healthcare · Health Information Services
A$2.60 (+5.69%) as of
Key statistics
- Market cap
- 426.51M
- Forward P/E
- -22.73
- EPS (TTM)
- -0.1700
- Dividend yield
- 0.00%
- 52-week range
- 1.9950 – 6.4900
- Beta
- 0.65
- Revenue (TTM)
- 28k
- Profit margin
- 0.00%
- Analyst target
- A$5.40
- Volume
- 706.52k
About Artrya Limited
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- West Perth, WA, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.